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INTRODUCTION
Overactive bladder (OAB) is a common disorder that adversely 
affects the quality of life of patients and brings a heavy socio-
economic burden [1]. OAB was first described by Paul Abrams 
in 1997 (quoted from [2]). According to the International Con-
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Purpose: To determine the proportion of patients with undetected symptoms of overactive bladder by using the overactive 
bladder-validated 8 (OAB-V8) screening questionnaire and investigate these symptoms were undetected in female patients 
who were hospitalized.
Methods: We invited 2,250 female patients hospitalized in the Aegean region of Turkey to answer a self-administered ques-
tionnaire. The questionnaire included questions on evidence of lower urinary tract symptoms (OAB-V8), relevant medical 
history, and demographic data. Patients with a total OAB-V8 score≥8 were defined as having OAB symptoms.
Results: The proportion of patients with OAB symptoms in this study was 40.6%. Nearly 57% of the patients with OAB symp-
toms had not been previously admitted to any hospital for lower urinary tract symptoms (LUTS). The two most common rea-
sons why women with OAB symptoms did not admit themselves to a hospital because of LUTS were as follows: “I did not 
think I had a disease” and “The symptoms did not bother me,” with a response rate of 74.7%. The mean OAB-V8 scores of the 
patients with these two responses were significantly lower than those of the other patients (P<0.001).
Conclusions: This is the first study to demonstrate a significant proportion of women with undetected OAB symptoms. The 
main reasons the women did not admit themselves to a hospital were their unawareness of the disease and because the LUTS 
were not bothersome. Public awareness programs on this disease may resolve this problem.
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tinence Society, it is characterized by urinary urgency, with or 
without urge incontinence, usually with frequency and noctu-
ria, in the absence of causative infection or pathological condi-
tions [3]. Earlier studies reported the prevalence of OAB in a 
wide spectrum, ranging from 2% to 53% [4-14]. Unfortunately, 
these studies had methodological limitations [4,5,7,8,10,12,13] 
or were not population based [6,9,11,14]. Despite the fact that 
OAB has a significant impact on patients’ quality of life and 
daily activities, it is frequently unreported and underdiagnosed 
[15]. This is the other reason of the discrepant results of previ-
ous reports about prevalence. This lack of recognition of OAB 
can be associated with patients’ lack of understanding of the 
disorder, besides the fact that they tend not to talk about their 
symptoms or associate them with aging [16]. Self-assessment 
questionnaires and registries are useful for the diagnosis. How-
ever, these tests are not generally applied in daily practice [15].
 The overactive bladder questionnaire (OAB-q) was first de-
veloped by Coyne et al. [17] in 2002 for assessment of symp-
toms and quality of life of patients with OAB. Subsequent stud-
ies developed shorter forms of the OAB-q. Overactive bladder-
validated 8 (OAB-V8) is one of these shorter forms and was 
translated into 14 languages in 2006 by Acquadro et al. [18]. 
The aim of our study was to determine the proportion of female 
patients with undetected OAB symptoms who refer to hospitals 
for other diseases by using the OAB-V8 questionnaire and to 
investigate why these patients did not mention about their 
symptoms.
MATERIALS AND METHODS
A multicenter, observational epidemiological study was con-
ducted between December 2013 and August 2014. Female pa-
tients aged ≥18 years who were admitted to 4 different hospi-
tals in the Aegean region of Turkey were asked to answer a self-
administered questionnaire. The study questionnaire was devel-
oped by the study team and consisted of four parts as follows: 
(1) sociodemographic data; (2) OAB-V8 (Turkish version of 
OAB-V8 validated by Tarcan et al. [19]); (3) 2 questions about 
the treatment received by patients with OAB symptoms who 
previously referred to a hospital for their symptoms; (4) two 
questions for patients with OAB symptoms who had not been 
previously admitted to any hospital for their symptoms (Table 
1). Patients with undetected OAB symptoms were defined as 
those having OAB-V8 scores≥8 who had not been admitted to 
any hospital because of LUTS. These patients were asked why 
they had not admitted themselves to any hospital because of the 
aforementioned complaints. They were asked to choose the 
most appropriate answer. The study protocol was approved by 
the local ethics committee (approval number: 20478486-320).
 Statistical analysis was performed by using SPSS ver. 16.0 
(SPSS Inc., Chicago, IL, USA). The patients were divided into 5 
groups according to age, and the proportion of patients with 
OAB-V8 scores≥8 in these age groups was calculated. The pa-
tients with OAB V8 scores≥8 were divided into two groups ac-
cording to whether or not they had been admitted to a hospital 
because of these symptoms. The demographic features of the 2 
groups were statistically compared. The patients with undetect-
ed OAB symptoms were divided into 6 groups according to 
their responses to the question, “Why did you not admit your-
self to any hospital because of these symptoms before?” The 6 
groups were compared in terms of OAB V8 scores. A P-value 
<0.05 was considered statistically significant.
RESULTS
We enrolled 2,250 female patients with a mean age (range) of 
41.2±15.4 years (18–95 years) who agreed to participate in the 
study. The proportion of patients with OAB symptoms in this 
study was 40.6%. A strong positive correlation was found be-
tween age and OAB-V8 score (P <0,001, r =0.42). Table 2 
shows a comparison of demographic features between the pa-
tients with OAB V8 scores of ≥8 (group 1) and <8 (group 2). 
Statistically significant differences in mean age, age range, mari-
tal status, educational level, work status, and living status were 
found between the two groups (P<0.001). Of the patients with 
undetected OAB symptoms (group 3), 57% had newly diag-
nosed OAB and 43% (group 4) had been previously admitted 
to a hospital because of OAB symptoms. Table 3 shows a com-
Table 1. The questions administered to the patients with OAB-
V8 scores≥8
H ave you been admitted to any hospital for these symptoms before? 
Yes or No
If your answer is yes, please continue.
 1. Which clinics did you admit yourself for these complaints?
 2. Did you take any medications?
If your answer is no, please continue.
 1.  Why did you not admit yourself to any hospital for these com-
plaints?
 2. Which clinic do you think you should go to?
OAB-V8, overactive bladder-validated 8.
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parison of demographic features between the patients in group 
3 and those in group 4. Although significant differences in 
mean age, age range, work status, and living status were found 
between the patients in group 3 and those in group 4, no signif-
icant differences in marital status, educational level, and income 
level were found between the groups (Table 3).
 The ratio of the reasons the OAB symptoms were undetect-
ed, and the mean ages and mean OAB V8 scores for different 
causes of the patients are provided in Table 4. The two most 
common reasons why the women with OAB symptoms did not 
admit themselves to a hospital because of LUTS were as follows: 
(1) “I did not think I had a disease.” and (2) “The symptoms did 
not bother me.” The mean OAB-V8 scores of the patients with 
these 2 responses were significantly lower than those of the pa-
tients with other responses (11.34 vs. 16.29, P<0.001). Of the 
patients who responded to the question, “Why did you not ad-
mit yourself to a hospital for these symptoms before?,” 74.7% 
gave the 2 responses.
DISCUSSION
In the present study, our objective was to determine the propor-
Table 2. Comparison of demographic features between the pa-
tients in the two groups according to OAB-V8 scores  
Variable
OAB-V8 score
P-value
≥8 (group 1) <8 (group 2)
Number 914 1,334
Age (yr) 49.07±14.13 39.93±14.48 <0.001
Age range
   <30
   30–39
   40–49
   50–59
   >59
  
103 (16.7)
119 (28.3)
254 (49.2)
225 (59.1)
213 (68.1)
  
515 (83.3)
301 (71.7)
262 (50.8)
156 (40.9)
100 (31.9)
<0.001
Marital status
   Married 
   Single
   Divorced
  
604 (43.7)
152 (24.3)
157 (64.6)
  
776 (56.3)
472 (75.7)
86 (35.4)
<0.001
Education
   Primary school
   Secondary school
   High school
   University
  
394 (55.1)
116 (46.7)
195 (35.1)
201 (27.9)
  
320 (44.9)
132 (53.3)
360 (64.9)
517 (72.1)
<0.001
Work status
   Student
   Working
   Retired 
   Housewife
  
35 (11.3)
321 (37.8)
102 (59.3)
456 (49.5)
  
273 (88.7)
526 (62.2)
70 (40.7)
465 (50.5)
<0.001
Income level (TL)
   <1,000
   1,000–3,000
   3,000–5,000
   >5,000
  
429 (40.4)
429 (40.5)
42 (43.7)
13 (43.3)
  
632 (59.6)
630 (59.5)
54 (56.3)
17 (56.7) 
0.900
Living status
   Village
   Town
   City
  
130 (54.6)
196 (42.5)
584 (37.8)
  
108 (45.4)
265 (57.5)
960 (62.2)
<0.001
Values are presented as mean±standard deviation or number (%).  
OAB-V8, overactive bladder-validated 8; TL, Turkish Lira. 
Table 3. Comparison of demographic features between the pa-
tients in the 2 groups according to their responses to the ques-
tion, “Have you been admitted to any hospital because of OAB 
symptoms?” 
Variable
OAB-V8 score≥8
P-value
No (group 3) Yes (group 4)
Number 521 393
Age (yr) 46.40±14.82 50.90±14.43 <0.001
Age range
   <30
   30–39
   40–49
   50–59
   >59
  
65 (57.6)
150 (60.0)
118 (54.4)
101 (47.5)
87 (72.0)
  
48 (42.4)
100 (40.0)
99 (45.6)
112 (52.5)
34 (28.0
<0.001
Marital status
   Married 
   Single
   Divorced
  
345 (57.4)
91 (55.5)
85 (57.5)
  
257 (42.6)
73 (44.5)
63 (42.5)
0.810
Education
   Primary school
   Secondary school
   High school
   University
  
213 (56.3)
56 (51.0)
106 (53.9)
146 (63.8)
  
165 (43.7)
54 (49.0)
91 (46.1)
83 (36.2)
0.100
Work status
   Student
   Working
   Retired 
   House wife 
  
37 (77.1)
182 (57.6)
48 (45.8)
254 (56.6)
  
11 (22.9)
134 (42.4)
53 (54.2)
195 (43.4)
<0.001
Income level (TL)
   <1,000
   1,000–3,000
   3,000–5,000
   >5,000
  
238 (56.6)
256 (58.9)
21 (46.7)
6 (46.2)
  
183 (43.4)
179 (41.1)
24 (53.3)
7 (53.8)
0.610
Living status
   Village
   Town
   City
  
77 (61.6)
103 (54.5)
341 (56.9)
  
48 (38.4)
86 (45.5)
259 (43.1)
<0.05
Values are presented as mean±standard deviation or number (%).  
OAB-V8, overactive bladder-validated 8; TL,Turkish Lira. 
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tion of female patients with undetected OAB symptoms who 
attended tertiary hospitals because of varied complaints re-
ferred to different departments (urology, gynecology, ophthal-
mology, internal medicine, general surgery, etc.) in the Aegean 
region of Turkey by using a self-administered questionnaire. 
Cheung et al. [1] reported that the prevalence of OAB in wom-
en aged 18 to 70 years (mean, 42.2 years) was 30%. The ages of 
the patients in their study were similar to those of our patients. 
The proportion of patients with OAB symptoms in our study 
was higher than that of patients OAB in the previous study. 
Two reasons of this difference may be that our study group 
consisted of patients with different complaints and our study 
was not epidemiological. Previous epidemiological studies con-
sistently report increased prevalence of OAB with age [20]. 
Similarly, the present study showed that the proportion of fe-
male patients with OAB symptoms increased with age. The de-
mographic data of groups 1 and 2 were compared, and statisti-
cally significant differences were found between the 2 groups, 
except for income status (Table 1). Overall, the findings of this 
statistical analysis show that aging is an important factor of 
OAB symptoms. For example, the proportion of patients with 
OAB symptoms was lower among single women than among 
divorced and married women, and among female students and 
working women than among housewives and retired women 
(Table 1).
 We used the OAB-V8 questionnaire in face-to-face inter-
views with patients to evaluate OAB symptoms. This type of 
data collection was reported to be more accurate than the use 
of postal questionnaires and telephone interviews because the 
questions can be clarified before answering [21]. We found that 
57% (group 3) of the 914 patients with OAB symptoms had not 
been admitted to a hospital because of their LUTS, whereas 393 
patients (group 4) had been admitted to a hospital for their 
symptoms. We compared demographic features between the 
patients in group 3 and those in group 4. No statistically signifi-
cant differences in marital status, educational level, and income 
level were found. The mean age of the patients in groups 3 and 
4 were 46.4 and 50.9 years (P<0.001). The work status of the 
patients with OAB symptoms was evaluated, and a statistically 
significant difference was found between the patients in group 
3 and those in group 4. This discrepancy depends on the differ-
ence in the number of students between the 2 groups. Group 3 
had more students than group 4, and the difference was statisti-
cally significant (Table 3). Overall, these findings show that 
younger patients with OAB symptoms do not prefer to go to a 
hospital for their symptoms. When we investigated the living 
status of the patients in groups 3 and 4, we found that most of 
the patients living in the village did not attend a hospital be-
cause of LUTS (Table 3). This may be due transportation diffi-
culties from the villages to hospitals.
 The two most common responses that accounted for 74.7% 
of all the responses to the question, “Why have you not referred 
to a hospital because of these symptoms before?,” were “I think 
I did not have a disease.” and “The symptoms did not bother 
me.” (Table 4). The mean OAB-V8 score of the patients who did 
not think the LUTS were bothersome was 9.6. The mean OAB-
V8 score of the patients who answered, “I did not think it was a 
disease,” was 12.79. Coyne et al. [22] reported that the model 
identifying patients with a diagnosis of probable OAB had a 
sensitivity and specificity of 98.0 and 82.7, respectively. They 
found that for OAB-V8 scores≥8, the odds ratio for probable 
OAB was 95.7 (95% confidence interval, 29.3–312.4). They also 
recommended that the OAB-V8 performed well in helping cli-
nicians identify patients with bothersome OAB symptoms in a 
primary care setting. On the other hand, Muhilan et al. [23] re-
ported that for OAB screening, an optimum OAB-V8 screen-
Table 4. Mean OAB-V8 scores and ages according to the patients’ responses   
Why did you not refer to a hospital because of these symptoms? No. of patients Age (yr) OAB-V8 score
I did not think it was a disease. 209 (40.1) 46.45±14.43 12.73±6.23
The symptoms did not bother me. 183 (35.1) 45.12± 15.04 9.62±5.13
I was ashamed to seek treatment. 73 (14.0) 48.01±13.45 16.34±7.13
I did not know where I should go to. 31 (5.9) 50.41±15.42 14.56±5.71
I had no time. 20 (3.8) 56.09±12.13 17.13±7.60
Others 5 (0.9) 50.51±13.34 18.22±5.11
Values are presented as number (%) or mean±standard deviation.    
OAB-V8, overactive bladder-validated 8.    
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ing score >12 had a sensitivity of 94.7% and a specificity of 
83.4%. In a study in Turkey, Tarcan et al. [19] found that the 
sensitivity and specificity of OAB-V8 scores>8.5 for the diag-
nosis of OAB were 90% and 59%, respectively, and those of 
OAB-V8 scores>11.5 were 80% and 78%, respectively. In our 
study, OAB V8 scores≥8 were used in identifying patients with 
OAB symptoms. With this cutoff OAB V8 score, we found that 
34.9% of the patients with OAB symptoms did not consider 
their LUTS bothersome. Cetinel et al. [21] evaluated only the 
prevalence of undetected urinary incontinence (UI) in women 
in Turkey and found that although the crude prevalence of fe-
male UI was found to be high (36%), more than half (53%) of 
incontinent women had nonbothersome UI. They also reported 
that most incontinent female patients did not seek medical 
help, whereas the degree of discomfort due to the symptoms 
was found to be the only independent factor that increased the 
help-seeking behavior of incontinent women. We suggest that 
this cut off OAB-V8 score for the diagnosis of OAB should be 
reconsidered according to geographical region.
 Despite the high prevalence of OAB, many afflicted patients 
remain undiagnosed or untreated [1]. We found that 57% of 
the patients with OAB symptoms in our study population re-
mained undiagnosed. The most common responses aside from 
the aforementioned two most common ones were “Ashamed to 
seek treatment,” “I did not know where I should go.” and “I had 
no time.” We think that these patients did not have enough in-
formation about OAB and LUTS. To avoid this situation, pri-
mary care practitioners should evaluate patients with LUTS by 
using self-administered questionnaires. Patients with OAB 
symptoms should be given information about OAB and, if nec-
essary, referred to secondary or tertiary hospitals.
 Our present study has some methodological limitations, the 
most important of which is its being not population based. On 
the other hand, the large number of participating centers, in-
cluding universities, and training and research hospitals, in the 
Aegean region of Turkey makes our study valuable. The other 
important limitation of our study is that the subjects were not 
evaluated for possible urinary tract infection, genitourinary 
cancers, contracted bladder, loop diuretics, pregnancy, and pu-
erperal conditions. Future studies about this topic may evaluate 
the above-mentioned conditions as exclusion criteria.
 In conclusion, the high proportion of patients with OAB 
symptoms in our study suggests that the needs of many of them 
may not have been met by their primary care providers. Pa-
tients with LUTS should be given information about OAB and 
LUTS by primary care providers. We also suggest that this in-
formation should be provided to people via the Internet and 
media by societies in order to increase their awareness. When 
OAB-V8 (score≥8) was used in the diagnosis of OAB, one of 
every three patients with OAB symptoms did not consider their 
disorder bothersome. Further studies should reevaluate these 
patients with further tests and should reconsider the threshold 
OAB-V8 score.
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